These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 36120320)
21. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction. Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306 [TBL] [Abstract][Full Text] [Related]
22. IGF2BP3 is an essential N Xu X; Cui J; Wang H; Ma L; Zhang X; Guo W; Xue X; Wang Y; Qiu S; Tian X; Miao Y; Wu M; Yu Y; Xu Y; Wang J; Qiao Y Mater Today Bio; 2022 Dec; 17():100503. PubMed ID: 36457846 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014 [TBL] [Abstract][Full Text] [Related]
24. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098 [TBL] [Abstract][Full Text] [Related]
25. The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model. Fei L; Sun G; Sun J; Wu D Bioengineered; 2022 Mar; 13(3):7622-7634. PubMed ID: 35263199 [TBL] [Abstract][Full Text] [Related]
26. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma. Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747 [TBL] [Abstract][Full Text] [Related]
27. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566 [TBL] [Abstract][Full Text] [Related]
28. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related]
29. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
31. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma. Yu Y; Liang C; Tang Q; Shi Y; Shen L Gene; 2024 Feb; 894():147989. PubMed ID: 37972699 [TBL] [Abstract][Full Text] [Related]
32. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma. Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785 [TBL] [Abstract][Full Text] [Related]
33. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
34. Analysis of N6-Methyladenosine Methylation Modification in Fructose-Induced Non-Alcoholic Fatty Liver Disease. Luo Y; Zhang Z; Xiang L; Zhou B; Wang X; Lin Y; Ding X; Liu F; Lu Y; Peng Y Front Endocrinol (Lausanne); 2021; 12():780617. PubMed ID: 34950107 [TBL] [Abstract][Full Text] [Related]
35. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y Front Genet; 2020; 11():994. PubMed ID: 33193582 [TBL] [Abstract][Full Text] [Related]
36. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors. Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074 [TBL] [Abstract][Full Text] [Related]
37. The Significance of N6-Methyladenosine RNA Methylation in Regulating the Hepatitis B Virus Life Cycle. Moon JS; Lee W; Cho YH; Kim Y; Kim GW J Microbiol Biotechnol; 2024 Feb; 34(2):233-239. PubMed ID: 37942519 [TBL] [Abstract][Full Text] [Related]
38. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
39. Function of N6-Methyladenosine Modification in Tumors. Zhang N; Zuo Y; Peng Y; Zuo L J Oncol; 2021; 2021():6461552. PubMed ID: 34858499 [TBL] [Abstract][Full Text] [Related]
40. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]